XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments (Q43084908)
Jump to navigation
Jump to search
scientific article published on 26 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments |
scientific article published on 26 April 2010 |
Statements
1 reference
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments (English)
1 reference
1 reference
Tina Bagratuni
1 reference
Ping Wu
1 reference
David Gonzalez de Castro
1 reference
Emma L Davenport
1 reference
Nicholas J Dickens
1 reference
Kevin Boyd
1 reference
David C Johnson
1 reference
Walter Gregory
1 reference
Gareth J Morgan
1 reference
Faith E Davies
1 reference
26 April 2010
1 reference
Identifiers
1 reference